Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus‐specific glycoproteins gB or gD
- 1 September 1985
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 17 (1), 9-18
- https://doi.org/10.1002/jmv.1890170103
Abstract
Groups of 5-week-old BALB/c mice were immunized intraperitoneally with approximately 10 μg of purified alum-precipitated glycoprotein gB or gD of either herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) origin. Control mice received injections of alum-precipitated 1 % bovine serum albumin (BSA). Following a second immunization 4 weeks later, seroconversion was confirmed by demonstrating the presence of glycoprotein-specific antibody by immune precipitation. All animals were challenged with lethal doses of either HSV-1 or HSV-2 by footpad inoculation and assessed for acute virus-induced neurological disease and the development of ganglionic latency. Whereas 70% of control (BSAimmunized) HSV- 1 -infected animals developed ascending myelitus and died, 100% of mice immunized with either gB-1, gB-2, gD-1, or gD-2 antigens remained free of clinical illness and survived HSV-1 challenge. In contrast, gB-1 or gB-2-immunized mice were not protected against acute HSV-2-induced neurological disease and showed a mortality rate of 60–90% (equivalent to that seen in controls), although mean survival times were prolonged. However, significant protection against HSV-2 challenge was observed with gD-1 or gD-2 immunization. When sacral ganglia were removed from surviving mice 9–12 months after virus challenge, latent virus was detected in all gB- or gD-immunized animals, although the extent of latent infection was restricted. These results provide evidence that glycoprotein gD might be superior to glycoprotein gB as an immunogen for the control of acute HSV-1 and HSV-2 neurological disease in mice. However, neither glycoprotein prevents ganglionic latency, the source of virus for recurrent herpesvirus infections.Keywords
This publication has 40 references indexed in Scilit:
- Relative Titers of Antibodies to Individual Polypeptide Antigens of Herpes Simplex Virus Type 1 in Human SeraThe Journal of Infectious Diseases, 1983
- Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gB (VP7)Virology, 1982
- Experimental Infection of Inbred Mice with Herpes Simplex Virus. III. Comparison between Newborn and Adult C57BL/6 MiceJournal of General Virology, 1982
- A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1Virology, 1981
- Comparative neurovirulence and latency of hsv1 and hsv2 following footpad inoculation in miceJournal of Medical Virology, 1980
- Acute and Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Immune Control and Virus ReactivationJournal of General Virology, 1979
- Neural spread of herpes simplex virus types 1 and 2 in mice after corneal or subcutaneous (footpad) inoculationJournal of the Neurological Sciences, 1978
- Latent Herpes Simplex Virus Infection of MiceJournal of Neuropathology and Experimental Neurology, 1978
- Invasion of the Central Nervous System by Herpes Simplex Virus Type 1 after Subcutaneous Inoculation of Immunosuppressed MiceThe Journal of Infectious Diseases, 1975
- INFLUENCE OF AGE ON SUSCEPTIBILITY TO VIRUS INFECTIONS WITH PARTICULAR REFERENCE TO LABORATORY ANIMALSAnnual Review of Microbiology, 1952